Elemental diet in the treatment of orofacial Crohn's disease

Cameron, E.A.B.; Middleton, S.J.
January 2003
Gut;Jan2003, Vol. 52 Issue 1, p143
Academic Journal
Presents the case of a 12-year-old boy with orofacial granulomatosis, a condition in which granulomatous lesions are found in the mouth and face. Consistency of granulomatous inflammation with a clinical diagnosis of Crohn's disease; Treatment of the condition with elemental diets which are liquid feeds containing protein as amino acids and carbohydrates as maltodextrins.


Related Articles

  • CONTROLLING INFLAMMATORY BOWEL DISEASE A NATURALLY DERIVED APPROACH.  // Nutraceutical Business & Technology;Mar2011, Vol. 7 Issue 2, p16 

    The article focuses on the growth of medical foods wit gut or digestive health claims. It references the development of a naturally derived product by Provexis PLC, wherein the interaction between the Escherichia coli in Crohn's disease and the epithelial cells can be inhibited. It states that...

  • Clinical importance of n-3 fatty acid-rich diet and nutritional education for the maintenance of remission in Crohn's disease. Tsujikawa, Tomoyuki; Satoh, Jin; Uda, Katsuhiro; Ihara, Takashi; Okamoto, Toshihiko; Araki, Yoshio; Sasaki, Masaya; Fujiyama, Yoshihide; Bamba, Tadao // Journal of Gastroenterology;2000, Vol. 35 Issue 2, p99 

    Abstract: Elemental diet (ED) therapy has been established as primary therapy for Crohn's disease, and home enteral nutrition (HEN) has been reported to control relapse at a dose of more than 30kcal/kg of ideal body weight. However, a decrease in ED compliance with long-term use is becoming...

  • Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.  // Inflammatory Bowel Disease Monitor;2012, Vol. 13 Issue 2, p68 

    Hanai et al. studied 95 adult patients with Crohn's disease in clinical remission who were randomly assigned to mercaptopurine (n=30), partial elemental diet (n=32), or no active treatment (n=33). At 2 years of follow-up, 17 of 30 (57%) mercaptopurine, 14 of 32 (44%) elemental diet, and seven of...

  • Enteral nutrition for maintaining remission in patients with quiescent Crohn's disease: current status and future perspectives. Nakahigashi, Maki; Yamamoto, Takayuki; Sacco, Rodolfo; Hanai, Hiroyuki; Kobayashi, Fumio // International Journal of Colorectal Disease;Jan2016, Vol. 31 Issue 1, p1 

    Purpose: The value of enteral nutrition (EN) as maintenance therapy in patients with quiescent Crohn's disease (CD) has not been fully evaluated. The purpose of this study was to review the efficacy of EN for the maintenance of remission in patients with quiescent CD. Methods: Seven prospective...

  • A health economic analysis of combination therapy with infliximab plus elemental diet for moderately to severely active Crohn's disease. Saito, Shota; Shimizu, Utako; Zhang Nan; Yokoyama, Junji; Watanabe, Mayumi; Terajima, Kenshi; Akazawa, Kohei // Health (1949-4998);Jan2014, Vol. 6 Issue 1, p107 

    Although infliximab (IFX) is effective for inducing and maintaining remission in patients with Crohn's disease (CD), it is much more expensive than other treatments. The aim of this study is to evaluate the cost-effectiveness of several therapies, including IFX, for moderately to severely active...

  • Crohn's disease: Choosing the right therapy. Frank, Michael S.; Ott, David J. // Patient Care;10/30/1993, Vol. 27 Issue 17, p52 

    Features several therapeutic drugs and medications for the treatment of Crohn's disease. Sulfasalazine; Pentasa; Oral mesalamine agents; Corticosteroids; Antidiarrheals; Antibiotics; Immunosuppressive drugs; Mercaptopurine; Methotrexate; Cyclosporine; Nutritional support. INSETS: The outlook...

  • Anti-Interleukin-6 Therapy for Crohn's Disease. Ito, H. // Current Pharmaceutical Design;Feb2003, Vol. 9 Issue 4, p295 

    Proinflammatory cytokines have been demonstrated to play a crucial role in the pathogenesis and physiopathology of various chronic inflammatory conditions including Crohn's disease (CD). Among these cytokines, interleukin-6 (IL-6) must be especially important because increased serum...

  • Methotrexate for the Treatment of Crohn's Disease. Feagan, Brian G.; Rochon, James; Fedorak, Richard N.; Irvine, E. Jan; Wild, Gary; Sutherland, Lloyd; Steinhart, A. Hillary; Greenberg, Gordon R.; Gillies, Richard; Hopkins, Marybeth; Hanauer, Stephen B.; McDonald, John W.D. // New England Journal of Medicine;2/2/95, Vol. 332 Issue 5, p292 

    Background: Although corticosteroids are highly effective in improving symptoms of Crohn's disease, they may have substantial toxicity. In some patients, attempts to discontinue corticosteroids are unsuccessful. Methods: We conducted a double-blind, placebo-controlled multicenter study of weekly...

  • Methotrexate for Chronic Diseases in Adults. Weinblatt, Michael E. // New England Journal of Medicine;2/2/95, Vol. 332 Issue 5, p330 

    Comments on an article in the February 2, 1995 issue of the `New England Journal of Medicine,' by Feagan and colleagues. The report on a study which found that in a 16-week double-blind trial, intramuscular methotrexate was more effective than placebo in improving symptoms and reducing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics